Magellan is looking for ways to boost its value. Since April 2018, its shares have dropped nearly 40 percent.
In response, the company intends to start a multiyear improvement plan to shore up finances.
People familiar with the plan say Magellan is considering being acquired by other companies.
Starboard has a 9.8 percent stake in the company.
Read the full report here.
More articles on pharmacy:
FTC settles with Teva over ‘pay-for-delay’ deals
Top 10 fatal or harmful prescribing errors
Civica Rx will start as middleman for drugmakers, hospitals, Bloomberg says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
